Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...
Regeneron’s (REGN) treatment of lipodystrophy, mibavademab, was granted FDA orphan designation, according to a post on the agency’s website. See what stocks are receiving Strong Buy ratings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback